| Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ... Cancer discovery 6 (8), 827-837, 2016 | 968 | 2016 |
| Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial JR Westin, F Chu, M Zhang, LE Fayad, LW Kwak, N Fowler, J Romaguera, ... The lancet oncology 15 (1), 69-77, 2014 | 650 | 2014 |
| Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion Y Hailemichael, Z Dai, N Jaffarzad, Y Ye, MA Medina, XF Huang, ... Nature medicine 19 (4), 465-472, 2013 | 504 | 2013 |
| Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance R Jacamo, Y Chen, Z Wang, W Ma, M Zhang, EL Spaeth, Y Wang, ... Blood, The Journal of the American Society of Hematology 123 (17), 2691-2702, 2014 | 319 | 2014 |
| Genomic, pathway network, and immunologic features distinguishing squamous carcinomas JD Campbell, C Yau, R Bowlby, Y Liu, K Brennan, H Fan, AM Taylor, ... Cell reports 23 (1), 194-212. e6, 2018 | 310 | 2018 |
| Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality J Ishizawa, SF Zarabi, RE Davis, O Halgas, T Nii, Y Jitkova, R Zhao, ... Cancer cell 35 (5), 721-737. e9, 2019 | 278 | 2019 |
| Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma DJ Kuhn, Z Berkova, RJ Jones, R Woessner, CC Bjorklund, W Ma, ... Blood, The Journal of the American Society of Hematology 120 (16), 3260-3270, 2012 | 214 | 2012 |
| Edge-based scoring and searching method for identifying condition-responsive protein–protein interaction sub-network Z Guo, Y Li, X Gong, C Yao, W Ma, D Wang, Y Li, J Zhu, M Zhang, D Yang, ... Bioinformatics 23 (16), 2121-2128, 2007 | 212* | 2007 |
| Protein arginine methyltransferase 5 is essential for growth of lung cancer cells Z Gu, S Gao, F Zhang, Z Wang, W Ma, RE Davis, Z Wang Biochemical Journal 446 (2), 235-241, 2012 | 198 | 2012 |
| ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies JO Ishizawa, K Kojima, D Chachad, P Ruvolo, V Ruvolo, RO Jacamo, ... Science signaling 9 (415), ra17-ra17, 2016 | 182 | 2016 |
| A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ... Cell systems 7 (4), 422-437. e7, 2018 | 155 | 2018 |
| Evidence of a role for activation of Wnt/β-catenin signaling in the resistance of plasma cells to lenalidomide CC Bjorklund, W Ma, ZQ Wang, RE Davis, DJ Kuhn, SM Kornblau, ... Journal of Biological Chemistry 286 (13), 11009-11020, 2011 | 154 | 2011 |
| Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy BS Cho, Z Zeng, H Mu, Z Wang, S Konoplev, T McQueen, M Protopopova, ... Blood, The Journal of the American Society of Hematology 126 (2), 222-232, 2015 | 116 | 2015 |
| Tonic B-cell receptor signaling in diffuse large B-cell lymphoma O Havranek, J Xu, S Köhrer, Z Wang, L Becker, JM Comer, J Henderson, ... Blood, The Journal of the American Society of Hematology 130 (8), 995-1006, 2017 | 114 | 2017 |
| Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment VL Battula, Y Chen, MG Cabreira, V Ruvolo, Z Wang, W Ma, S Konoplev, ... Blood, The Journal of the American Society of Hematology 122 (3), 357-366, 2013 | 102 | 2013 |
| Adoptive T-cell therapy improves treatment of canine non–Hodgkin lymphoma post chemotherapy CM O'Connor, S Sheppard, CA Hartline, H Huls, M Johnson, SL Palla, ... Scientific reports 2 (1), 249, 2012 | 92 | 2012 |
| Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia Q Zhang, B Riley-Gillis, L Han, Y Jia, A Lodi, H Zhang, S Ganesan, R Pan, ... Signal transduction and targeted therapy 7 (1), 51, 2022 | 89 | 2022 |
| Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition S Köhrer, O Havranek, F Seyfried, C Hurtz, GP Coffey, E Kim, ... Leukemia 30 (6), 1246-1254, 2016 | 81 | 2016 |
| Ischemia impairs the association between connexin 43 and M3 subtype of acetylcholine muscarinic receptor (M3-mAChR) in ventricular myocytes P Yue, Y Zhang, Z Du, J Xiao, Z Pan, N Wang, H Yu, W Ma, H Qin, ... Cellular Physiology and Biochemistry 17 (3-4), 129-136, 2006 | 76 | 2006 |
| RNA Polymerase I Inhibition with CX‐5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma HC Lee, H Wang, V Baladandayuthapani, H Lin, J He, RJ Jones, I Kuiatse, ... British journal of haematology 177 (1), 80-94, 2017 | 73 | 2017 |
